From: Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma
Cell line
CD33xCD33
EGFRxEGFR
EGFRxCD33
HER2xHER2
HER2xCD33
EGFRxHER2
SW1990
—
319
2554
2302
146,300
402
SW1990 EGFR-KO
3363
46,935
31,475
SW1990 HER2-KO
280
4358
2224